Healthcare provider profile · identity verified

Gerald A Kelty, M.D.

Family Practice · FORT WAYNE, IN · NPI 1700991320

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	478	127
Levothyroxine Sodium	Levothyroxine Sodium	319	78
Omeprazole	Omeprazole	301	81
Lisinopril	Lisinopril	269	81
Amlodipine Besylate	Amlodipine Besylate	261	73
Losartan Potassium	Losartan Potassium	194	46
Alprazolam	Alprazolam	179	37
Tamsulosin Hcl	Tamsulosin Hcl	165	53
Metformin Hcl	Metformin Hcl	160	43
Albuterol Sulfate Hfa	Albuterol Sulfate	141	50
Pantoprazole Sodium	Pantoprazole Sodium	124	36
Gabapentin	Gabapentin	123	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	123	34
Furosemide	Furosemide	119	37
Simvastatin	Simvastatin	117	32
Famotidine	Famotidine	112	29
Sertraline Hcl	Sertraline Hcl	111	30
Pravastatin Sodium	Pravastatin Sodium	105	32
Allopurinol	Allopurinol	94	27
Prednisone	Prednisone	92	76
Trazodone Hcl	Trazodone Hcl	91	27
Atenolol	Atenolol	88	24
Rosuvastatin Calcium	Rosuvastatin Calcium	88	27
Fluticasone Propionate	Fluticasone Propionate	86	30
Clonazepam	Clonazepam	83	13
Meloxicam	Meloxicam	82	33
Ozempic	Semaglutide	82	15
Escitalopram Oxalate	Escitalopram Oxalate	81	28
Carvedilol	Carvedilol	78	19
Tramadol Hcl	Tramadol Hcl	71	20
Fluoxetine Hcl	Fluoxetine Hcl	64	16
Pioglitazone Hcl	Pioglitazone Hcl	64	19
Metoprolol Succinate	Metoprolol Succinate	59	17
Glimepiride	Glimepiride	57	16
Metformin Hcl Er	Metformin Hcl	56	17
Hydrochlorothiazide	Hydrochlorothiazide	53	18
Finasteride	Finasteride	52	19
Montelukast Sodium	Montelukast Sodium	52	18
Metoprolol Tartrate	Metoprolol Tartrate	51	14
Nystatin	Nystatin	51	24
Breo Ellipta	Fluticasone/Vilanterol	47	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	47	16
Cephalexin	Cephalexin	46	28
Baclofen	Baclofen	44	11
Temazepam	Temazepam	43	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	42	suppressed
Spironolactone	Spironolactone	41	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	11
Triamcinolone Acetonide	Triamcinolone Acetonide	40	19
Glipizide Er	Glipizide	39	11
Potassium Chloride	Potassium Chloride	38	12
Lorazepam	Lorazepam	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	11
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Cefuroxime	Cefuroxime Axetil	32	30
Clopidogrel	Clopidogrel Bisulfate	32	11
Januvia	Sitagliptin Phosphate	32	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Cefprozil	Cefprozil	28	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	21
Buspirone Hcl	Buspirone Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	11
Eliquis	Apixaban	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Diazepam	Diazepam	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Amoxicillin	Amoxicillin	20	16
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Fluconazole	Fluconazole	17	12
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Valsartan	Valsartan	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Prempro	Estrogen,con/M-Progest Acet	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lactulose	Lactulose	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error